These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 3124801

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Topical tobramycin therapy of experimental Pseudomonas keratitis: an evaluation of some factors that potentially enhance efficacy.
    Davis SD, Sarff LD, Hyndiuk RA.
    Arch Ophthalmol; 1978 Jan; 96(1):123-5. PubMed ID: 414702
    [Abstract] [Full Text] [Related]

  • 23. Ciprofloxacin ointment versus ciprofloxacin drops for therapy of experimental Pseudomonas keratitis.
    Hobden JA, O'Callaghan RJ, Insler MS, Hill JM.
    Cornea; 1993 Mar; 12(2):138-41. PubMed ID: 8500320
    [Abstract] [Full Text] [Related]

  • 24. Topical ciprofloxacin treatment of Pseudomonas keratitis in rabbits.
    O'Brien TP, Sawusch MR, Dick JD, Gottsch JD.
    Arch Ophthalmol; 1988 Oct; 106(10):1444-6. PubMed ID: 3140772
    [Abstract] [Full Text] [Related]

  • 25. Effect of nitric oxide synthase inhibition in experimental Pseudomonas keratitis in rabbits.
    Er H, Turkoz Y, Ozerol IH, Uzmez E.
    Eur J Ophthalmol; 1998 Oct; 8(3):137-41. PubMed ID: 9793765
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Evaluation of corneal collagen shields as a drug delivery device for the treatment of experimental Pseudomonas keratitis.
    Silbiger J, Stern GA.
    Ophthalmology; 1992 Jun; 99(6):889-92. PubMed ID: 1630778
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effect of minimal antibiotic treatment on bacterial keratitis.
    Hodges EJ, Friedlaender MH, Lee A, Okumoto M.
    Cornea; 1989 Sep; 8(3):188-90. PubMed ID: 2501067
    [Abstract] [Full Text] [Related]

  • 30. The effect of topical ceftazidime on pseudomonas keratitis in rabbits.
    Kremer I, Robinson A, Braffman M, Drucker M, Goldenfeld M, Samra Z, Myszne-Daye N, Gaton D, Savir H.
    Cornea; 1994 Jul; 13(4):360-3. PubMed ID: 7924338
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Quinolones in collagen shields to treat aminoglycoside-resistant pseudomonal keratitis.
    Hobden JA, Reidy JJ, O'Callaghan RJ, Insler MS, Hill JM.
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2241-3. PubMed ID: 2173684
    [Abstract] [Full Text] [Related]

  • 36. Keratotomy model of pseudomonas keratitis: gentamicin chemotherapy.
    Brockman EB, Tarantino PA, Hobden JA, Hill JM, O'Callaghan RJ, Kaufman HE, Insler MS.
    Refract Corneal Surg; 1992 Nov; 8(1):39-43. PubMed ID: 1554638
    [Abstract] [Full Text] [Related]

  • 37. Comparative bioavailability and efficacy of fortified topical tobramycin.
    Gilbert ML, Wilhelmus KR, Osato MS.
    Invest Ophthalmol Vis Sci; 1987 May; 28(5):881-5. PubMed ID: 3570696
    [Abstract] [Full Text] [Related]

  • 38. Combined gentamicin-tobramycin-corticosteroid treatment. II. Effect on gentamicin-resistant Pseudomonas keratitis.
    Smolin G, Okumoto M, Leong-Sit L.
    Arch Ophthalmol; 1980 Mar; 98(3):473-4. PubMed ID: 6767466
    [Abstract] [Full Text] [Related]

  • 39. [Studies of tobramycin eye drops. Report 3. Therapeutic effect in experimental Peudomonas keratitis (author's transl)].
    Oishi M, Nishizuka K, Motoyama M, Ogawa T.
    Nippon Ganka Gakkai Zasshi; 1977 Nov 10; 81(11):1783-6. PubMed ID: 613826
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.